Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | SVP & Chief Commercial Officer | July 28, 2026 | July 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUEST DIAGNOSTICS INC
Report date July 28, 2026 · Filed July 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,335 |
Reported balance
After 2026-07-28 transaction · row 1
1 source rowRow 1 · 2026-07-28 · Sale · Disposed 1,600 · Balance 10,335 F1: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2026 Filed Jul 29, 2026 21:04 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,600 | $235.18 | $376,288.00 |
DisclosureSEC source: 0001022079-26-000087 · wk-form4_1785359086.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,335 F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| July 22, 2026 Filed Jul 27, 2026 20:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 34 | $206.81 | $7,031.44 |
DisclosureSEC source: 0001022079-26-000079 · wk-form4_1785184364.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,935 F1 · security: Represents an award of restricted share units. F2 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| April 20, 2026 Filed Apr 24, 2026 22:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 37 | $194.70 | $7,203.75 |
DisclosureSEC source: 0001022079-26-000044 · wk-form4_1777069381.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,901 F1 · security: Represents an award of restricted share units. F2 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:44 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 2,326 | $204.86 | $476,504.36 |
DisclosureSEC source: 0001022079-26-000030 · wk-form4_1772833481.xml · nonDerivative · entry 2 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,864 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:44 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 5,682 | $204.86 | $1,164,014.52 |
DisclosureSEC source: 0001022079-26-000030 · wk-form4_1772833481.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,190 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 188 | $204.86 | $38,513.68 |
DisclosureSEC source: 0001022079-26-000018 · wk-form4_1772660249.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,508 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 7,332 | $0.00 Strike: $204.96 | $0.00 |
DisclosureSEC source: 0001955265-26-000002 · wk-form4_1771625397.xml · derivative · entry 5 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,332 Underlying: Common Stock · 7,332 shares Expires 2036-02-18 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 230 | $206.99 | $47,607.70 |
DisclosureSEC source: 0001955265-26-000002 · wk-form4_1771625397.xml · nonDerivative · entry 3 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,681 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 205 | $210.01 | $43,052.05 |
DisclosureSEC source: 0001955265-26-000002 · wk-form4_1771625397.xml · nonDerivative · entry 2 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,911 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001955265-26-000002 · wk-form4_1771625397.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,116 F1 · security: Represents an award of restricted stock units. Read SEC document |
| January 28, 2026 Filed Feb 20, 2026 22:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 15 | $183.51 | $2,752.65 |
DisclosureSEC source: 0001955265-26-000002 · wk-form4_1771625397.xml · nonDerivative · entry 4 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,696 F3 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 21:28 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 100 | $143.33 Strike: $143.33 | $14,333.00 |
DisclosureSEC source: 0001955265-25-000004 · wk-form4_1763674087.xml · derivative · entry 5 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,484 Underlying: Common Stock · 100 shares Expires 2033-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 21:28 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 7,846 | $144.47 Strike: $144.47 | $1,133,511.62 |
DisclosureSEC source: 0001955265-25-000004 · wk-form4_1763674087.xml · derivative · entry 4 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,846 shares Expires 2032-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 21:28 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 7,946 | $187.35 | $1,488,683.10 |
DisclosureSEC source: 0001955265-25-000004 · wk-form4_1763674087.xml · nonDerivative · entry 3 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,530 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 21:28 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 100 | $143.33 | $14,333.00 |
DisclosureSEC source: 0001955265-25-000004 · wk-form4_1763674087.xml · nonDerivative · entry 2 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 21:28 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 7,846 | $144.47 | $1,133,511.62 |
DisclosureSEC source: 0001955265-25-000004 · wk-form4_1763674087.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,376 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| October 21, 2025 Filed Oct 24, 2025 22:09 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 15 | $189.08 | $2,836.16 |
DisclosureSEC source: 0001022079-25-000225 · wk-form4_1761343785.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,530 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| July 21, 2025 Filed Jul 25, 2025 20:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 17 | $167.49 | $2,847.35 |
DisclosureSEC source: 0001022079-25-000184 · wk-form4_1753475171.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,515 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| May 13, 2025 Filed May 14, 2025 21:12 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 874 | $175.31 | $153,220.94 |
DisclosureSEC source: 0001022079-25-000132 · wk-form4_1747257144.xml · nonDerivative · entry 2 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,498 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:12 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 874 | $175.72 | $153,579.28 |
DisclosureSEC source: 0001022079-25-000132 · wk-form4_1747257144.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,372 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| April 21, 2025 Filed May 2, 2025 20:30 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 25 | $164.42 | $4,110.53 |
DisclosureSEC source: 0001022079-25-000126 · wk-form4_1746217832.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,246 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 20:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 256 | $166.71 | $42,677.76 |
DisclosureSEC source: 0001022079-25-000100 · wk-form4_1743194708.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,221 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 1,823 | $173.74 | $316,728.02 |
DisclosureSEC source: 0001022079-25-000086 · wk-form4_1741210490.xml · nonDerivative · entry 2 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,477 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 5,317 | $173.74 | $923,775.58 |
DisclosureSEC source: 0001022079-25-000086 · wk-form4_1741210490.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,300 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 214 | $171.75 | $36,754.50 |
DisclosureSEC source: 0001022079-25-000069 · wk-form4_1740778392.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,983 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 242 | $169.71 | $41,069.82 |
DisclosureSEC source: 0001022079-25-000048 · wk-form4_1740173866.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,197 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 6,960 | $0.00 Strike: $165.30 | $0.00 |
DisclosureSEC source: 0001022079-25-000032 · wk-form4_1739572003.xml · derivative · entry 2 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,960 Underlying: Common Stock · 6,960 shares Expires 2035-02-12 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-25-000032 · wk-form4_1739572003.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,439 F1 · security: Represents an award of restricted stock units. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 403 | $164.30 | $66,214.15 |
DisclosureSEC source: 0001022079-25-000020 · wk-form4_1738964173.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,624 Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:28 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 4 | $158.03 | $632.10 |
DisclosureSEC source: 0001022079-25-000014 · wk-form4_1738358926.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,027 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| October 21, 2024 Filed Oct 25, 2024 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 4 | $149.39 | $597.55 |
DisclosureSEC source: 0001022079-24-000199 · wk-form4_1729888025.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,023 F1 · security: Represents an award of restricted share units. F2 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| July 24, 2024 Filed Jul 26, 2024 22:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 420 | $143.08 | $60,093.60 |
DisclosureSEC source: 0001022079-24-000168 · wk-form4_1722033208.xml · nonDerivative · entry 2 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,019 Read SEC document |
| July 22, 2024 Filed Jul 26, 2024 22:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 6 | $146.98 | $881.90 |
DisclosureSEC source: 0001022079-24-000168 · wk-form4_1722033208.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,439 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| March 26, 2024 Filed Mar 28, 2024 20:52 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 170 | $128.11 | $21,778.70 |
DisclosureSEC source: 0001022079-24-000089 · wk-form4_1711659150.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,433 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 225 | $126.36 | $28,431.00 |
DisclosureSEC source: 0001022079-24-000077 · wk-form4_1709329251.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,603 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 01:02 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 9,783 | $0.00 Strike: $127.81 | $0.00 |
DisclosureSEC source: 0001022079-24-000030 · wk-form4_1708131743.xml · derivative · entry 2 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,783 Underlying: Common Stock · 9,783 shares Expires 2034-02-14 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 01:02 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-24-000030 · wk-form4_1708131743.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,828 F1 · security: Represents an award of restricted share units. Read SEC document |
| March 24, 2023 Filed Mar 27, 2023 20:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 170 | $134.25 | $22,822.50 |
DisclosureSEC source: 0001022079-23-000073 · wf-form4_167994948437526.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,480 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 7,584 | $0.00 Strike: $143.33 | $0.00 |
DisclosureSEC source: 0001022079-23-000029 · wf-form4_167753393895974.xml · derivative · entry 2 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,584 Underlying: Common Stock · 7,584 shares Expires 2033-02-23 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-23-000029 · wf-form4_167753393895974.xml · nonDerivative · entry 1 DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,650 F1 · security: Represents an award of restricted share units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.